Medical Equipment Procurement

Procurement’s biggest negotiation power is NOT during Contract Negotiation phase. (It is BEFORE vendors are invited for tender) You miss this window, your leverage bleeds out daily. Negotiation | 16 SEP 2025 - Procurement's ability to negotiate, shape vendor terms, price and deliver fit-for-purpose contracts "Decays Like an Hourglass" once sourcing process begins. Here’s why timing is everything: #1. Peak Leverage (Supplier Registration & PQQ) →Vendors compete blindly for a spot. → Push for acceptance of non-negotiable terms early. → Include standard T&Cs with key terms. #2. Leverage Leak (RFP/Bid Clarification & Submission) →Vendors now see competition. →Use competitive tension; let vendors know no. of bids. →Clarify specs but do not negotiate scope. #3. Critical Decline (Best and Final Offer) →Shortlisted vendors smell victory; alternative shrink. →Keep ≥ 3 vendors until BAFO; Never reveal rankings. →Use scoring gaps to extract concessions. #4. Near-Zero Leverage (Contract Award) →Winner knows you’re committed. →Switching costs soar; too late for heavy lifts. → Focus on SLA fine-tuning not pricing or terms. Use prequalification to: ✅Force adherence to standard Ts&Cs ✅Eliminate non-compliant bidders early ✅Create FOMO in Vendors (Will we make the cut?) Negotiation is a race against your OWN process. The Early Bird Catches the Worm Front-load pressure or backpedal through concessions." Always include your non-negotiables into vendor registration gateways. What procurement stage have you seen early leverage make or break a deal? #Procurement #NegotiationTips #RFPTips #StrategicSourcing

The medical device industry is shifting faster than most leaders realize. And this chart makes it obvious. Abbott sits at $224B. Intuitive Surgical follows at $205B. Then the numbers cascade down through Boston Scientific, Stryker, Medtronic, and the rest. Here is the part people miss. Each jump in market cap reflects one thing: a company that figured out how to turn innovation into repeatable revenue. I learned this the hard way during a project with a mid-sized device manufacturer. They had brilliant engineers. They had strong clinical results. But their growth flatlined for three straight years. When I dug into the issue, the problem was not product performance. The problem was that the company was building devices the market was not ready to prioritize. Meanwhile, companies like Intuitive and Abbott were scaling systems that aligned directly with hospital economics and physician workflow. That gap is why some companies crack $200B while others stall at $2B. If you lead in medtech, this chart should not impress you. It should pressure you. Because every one of these companies earned their position by doing three things with relentless discipline: → They chose markets where demand was already accelerating. → They built ecosystems instead of isolated products. → They made adoption easy for clinicians, not just exciting for engineers. Growth in medtech is not random. It is the result of decisions that compound over years. Study the companies at the top. They are telling you exactly how the next decade will unfold.

𝗧𝗵𝗲 𝗧𝗿𝗶𝗽𝗹𝗲 𝗕𝗼𝘁𝘁𝗼𝗺 𝗟𝗶𝗻𝗲 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝗼𝗳 𝗥𝗲𝘀𝗽𝗼𝗻𝘀𝗶𝗯𝗹𝗲 𝗣𝗿𝗼𝗰𝘂𝗿𝗲𝗺𝗲𝗻𝘁 This year, we celebrate 30 years since John Elkington introduced the Triple Bottom Line (TBL), a concept still gaining in relevance. At the time, it was a revolutionary framework for balancing 𝗣𝗲𝗼𝗽𝗹𝗲, 𝗣𝗹𝗮𝗻𝗲𝘁 𝗮𝗻𝗱 𝗣𝗿𝗼𝗳𝗶𝘁. An idea which aligned with the principle of good corporate citizens and the principle shift from a share- to a stakeholder economy. 𝗪𝗵𝘆 𝗶𝘀 𝗶𝘁 𝗖𝗮𝗹𝗹𝗲𝗱 𝘁𝗵𝗲 𝗧𝗿𝗶𝗽𝗹𝗲 𝗕𝗼𝘁𝘁𝗼𝗺 𝗟𝗶𝗻𝗲? Traditionally, businesses focused solely on financial performance, their "𝗯𝗼𝘁𝘁𝗼𝗺 𝗹𝗶𝗻𝗲." The TBL expanded this idea to include two additional bottom lines, social (People) and environmental (Planet) performance, encouraging a holistic approach to value creation and promoting a more holistic view on good entrepreneurship. For Procurement, the TBL is still very relevant and an integral part of Sustainability and ESG frameworks. It's represented in: 𝗣𝗲𝗼𝗽𝗹𝗲: through responsible sourcing and promotion of ethical labor practices, supplier diversity, and fair treatment across the supply chain, measured through audits and due diligence activities. 𝗣𝗹𝗮𝗻𝗲𝘁: with sustainable and circular supply practices, reduction of carbon footprint measures and proactive green procurement strategies capturing the data points to monitor impact. 𝗣𝗿𝗼𝘀𝗽𝗲𝗿𝗶𝘁𝘆: beyond savings, include support for local economies, driving innovation, and creating long-term societal value with community work and minority owned business programs. TBL did not remain static, it was recalled by John Elkington in 2018 with the goal to further refine its application. For Procurement professionals, this means embedding these principles into every decision, from supplier evaluation to contract management and keeping oversight of initiatives and Corporate Social Responsibility programs. But to truly surface up the value and impact the 3 P's contribute to all three bottom lines, Procurement has to integrate a disciplined data collection and analysis approach into all things the function does. This challenge requires us to overcome the issue with fragmented systems, lack of standardisation or limited data capture and measurement tools to truly make the impact visible. ❓How is your organisation leveraging TBL principles to drive sustainability and value creation? ❓What tools do you use to measure and automate data collection across supplier networks and supply chain?

I’ve seen procurement teams save £ millions while destroying culture. Over the years, I’ve worked within organisations where procurement delivered impressive cost reductions, aggressive savings targets, and operational efficiencies. And on paper, the numbers looked successful. But once my team at GreenApples® rolled up the sleeves during transformation diagnostics and truly started unpeeling the onion, the reality underneath was often far more uncomfortable: • weak governance • conflict of interests • toxic leadership behaviours • fear-driven cultures • non-compliant spend practices • poor controls hidden behind “performance” • teams afraid to speak up • procurement policies existing on paper, but not in reality In one major transformation I led with my team Vlad Gradinariu across international operations, we were brought in to optimise spend, strengthen procurement capability, and improve operational performance. What we discovered went far beyond procurement. Teams opened up about behaviours, decisions, and practices that had been normalised for years. And this is the reality many organisations still underestimate: Procurement transformation is never only about cost. It is about courage. Because once the truth surfaces, leadership has two choices: ‼️ Confront it and transform the business properly, or ‼️ Protect the dysfunction because the truth is uncomfortable. Some leaders welcomed stronger governance, better controls, accountability, and transparency. Others were not ready to hear painful findings. True transformation requires: • independent governance • direct access to the board • empowered transformation experts • accountability at every level • pace and ownership • and the courage to challenge behaviours, not just processes Savings alone do not create sustainable businesses. Ethical leadership does. And procurement has a far bigger role in shaping that future than most organisations realise. At GreenApples®, we believe transformation starts with Boldness, Integrity, Teamwork, and Empathy. Not fear. Not silence. Not “saving money at any cost.” #Transformation #Procurement #ProcurementTransformation #EthicalLeadership #Savings #SupplyChain #Governance #Culture #SustainableBusiness #GreenApples

This report from Business & Human Rights Resource Centre, 'Bitter Truth: Migrant Worker Abuse in the Production of Sugar, Cocoa, and Coffee in Chiapas', published in April 2025, explores the harsh realities faced by agricultural workers in Chiapas, Mexico. It highlights a number of signficant issues with #supplychain and #procurement practices within the sector: 1. Labour Exploitation Migrant workers, including Indigenous peoples from Central America, suffer from low wages, excessively long hours, unsanitary housing, harassment, and violence, particularly targeting women. 2. Forced and Child Labour Cases of modern slavery persist, with children exposed to hazardous working conditions. 3. Health & Living Conditions Lack of healthcare and social benefits; overcrowded and unsafe housing; exposure to agrochemical pollution, linked to childhood leukaemia and other illnesses. 4. Climate Crisis Impacts Rising temperatures affect crop yields, particularly coffee. Environmental degradation due to deforestation, agrochemical use, and industrial waste mismanagement. 5. Transparency Issues Many firms lack public #humanrights policies, particularly in the sugarcane sector. The lessons for #procurement and #supplychain functions from the report include: - Strengthen supplier accountability and require suppliers to publicly disclose human rights policies. - Ensure compliance with fair labour standards. - Implement ethical sourcing practices, prioritise suppliers with strong human rights commitments. - Avoid sourcing from companies with documented labour abuses. - Monitor and audit supply chains, conduct regular audits to verify compliance with labour rights and environmental standards. - Use independent verification mechanisms. - Support sustainable procurement, encourage suppliers to reduce agrochemical use and adopt renewable energy. - Promote fair trade models that empower local communities. These recommendations aim to protect workers, increase transparency, and promote sustainability in agroindustry, but are obviously applicable across many similar supply chains.

One of the BIGGEST weaknesses I see while auditing PPC accounts "Toothpaste" VS "Toothpaste for Sensitive Teeth and Cavity Prevention" Which term should you bid on?  Which term should get the majority of your budget? Most brands take a top-down approach when targeting keywords. They invest the majority of their budget into the 5-10 keywords that are the most common sense. “Toothpaste”  “Mascara”  “Mouthwash”  “Deodorant” What’s the problem with this strategy? Well, you are not the only one with the common sense to bid on these terms. And when you are competing for real estate through an auction model, the more bidders you have, the higher the CPC’s will most likely be. In order to avoid having to constantly “Pay to play” for our top traffic, we invest in deep keyword research for every product we advertise. Instead of trying to compete directly on “Toothpaste” we are looking for all of the different ways a customer could be led to our listing. “Toothpaste for Sensitive Teeth and Cavity Prevention”  “Whitening toothpaste for sensitive teeth”  “Toothpaste with sensitivity protection and whitening” These long tail terms allow us to drive more incrementality for two reasons. 1. The more detailed the customer search is, the more likely they are to buy our product. (Higher CVR) Someone typing in ‘toothpaste” may want cheap toothpaste, whitening toothpaste, mint toothpaste, or charcoal toothpaste….we don't actually know, and yet we are having to compete against all of these products in search. Someone typing in “Toothpaste for sensitive teeth” knows exactly what they are looking for, and lucky enough, we have just the product for them! We have seen CVR being as much as 3x higher on our longtail terms due to this. 2. The more detailed the customer search is, the less likely it is that our competitors have thought to bid on this term. (Lower CPC) Everyone knows to bid on their top 3-5 terms. And everyone assumes that running their top terms in broad and phrase will also give them the coverage they want for all of their long tail searches. This is not the case. Most brands do not have the budget to afford their top terms AND their long tail terms in one campaign. We segment our campaigns for this reason. We want direct control over the budget going to our top terms, and our long-tail terms, so that we can adjust the budget based on performance. Higher CVR + Lower CPC = Much improved RoAS. This flexibility allows us to quickly react to the market and adjust profitability and scalability on an ongoing basis. ——— Why don't more brands do this? 🔶Top-down pressure from their leadership teams who only want to see their products showing up for their “top” keywords. 🔶 Lack of good keyword harvesting / bid management / budget distribution systems to make this scaleable. 🔶 Limited budgets and fear of NOT investing that whole budget into the top 4-5 keywords.

How to Win Mega EPC / PPP Rly Tenders in India. Winning a multi-billion-rupee Rly or infrastructure project is not about quoting the lowest price. It is about demonstrating superior execution capability, financial strength, and long-term credibility. 1. Start Before the Tender is Issued Serious bidders begin 6–12 months in advance. Study the DPR, visit the site, understand funding structures, and identify risks early. Focus only on opportunities aligned with your strengths. 2. Build Strong Consortiums Form strategic JVs early to bridge gaps in technical expertise, financial capability, signaling, telecoms, rolling stock, or construction. The best consortiums combine complementary strengths. 3. Master Compliance Use pre-bid meetings to clarify ambiguities and seek justified modifications. Ensure every required document is submitted correctly, as missing documents are rarely accepted later. 4. Avoid the “L1 Trap” Winning at an unsustainable price is not a victory. Stay competitive through value engineering, standardization, modular construction, and innovative design that lowers costs without compromising safety or quality. 5. Manage Risks Proactively Address concerns such as land acquisition, utility shifting, geotechnical issues, inflation, and delays with a clear mitigation plan. In PPP projects, focus on lifecycle costs, maintenance, and long-term operational performance. 6. Differentiate Through Technology & ESG Leverage BIM, Digital Twins, predictive maintenance, and data-driven asset management. Highlight sustainability through low-carbon materials, resource efficiency, biodiversity protection, and local skill development. 7. Build Credibility Trust matters. A strong track record, transparent engagement, capable bid teams, accurate financial models, and sector expertise create confidence in your ability to deliver. 8. Develop Business Intelligence Study competitors, past winners, bid strategies, and likely consortium formations. Learning from previous successes and failures provides a valuable bidding advantage. 9. Understand the Regulatory & Local Ecosystem Know railway standards, safety regulations, environmental requirements, labor laws, land policies, and local stakeholder dynamics. This reduces execution risk and strengthens bid quality. 10. Build the Right Network Engage with decision-makers, consultants, technology partners, financiers, local authorities, and industry experts. Understanding stakeholder expectations often influences success as much as technical capability. Bottom Line India’s infrastructure pipeline offers enormous opportunities, but mega tenders are rarely won on price alone. Success comes from the right mix of technical excellence, financial strength, business intelligence, regulatory knowledge, stakeholder engagement, innovation, risk management, and execution capability. Clients do not simply buy assets—they buy confidence that those assets will be delivered successfully. #Railways

Is a bird in the hand really worth it? Maybe!! But you have to prove it!! A good client comes to us which owns 325 Exterior Street in the Bronx and says that their tenant has approached them and wants to acquire the fee position of the property they are leasing. Simple deal, right? No, not so simple. How do you deal with this situation? As a broker, you could advise the owner to simply make the deal. The downside is that the owner will never know if they could have gotten a better price. So how do you deal with this situation? What we suggested to the owner is that we put the site on the market, get a bunch of offers, establish what “market” is, and then let the chips fall where they may. Another option would be to go get an appraisal and decide what to do based upon that appraisal. This approach has several potential negative outcomes associated with it. Who is going to rely on the appraisal? Is the appraiser conflicted? Who picks the appraiser? Neither party wanted this approach. The seller agreed with our approach to put the site on the market, get competitive offers, and then see if the buyer was still interested. In situations like this we have had before, especially when the buyer was not the lessee in the property, the price obtained dissuaded the buyer on the table from increasing their offer to allow them to be the successful bidder. In this case, we went to the market to obtain competitive offers. There were several folks who were interested in this great site and would bid on it. Many offers came in and at the end of the process, the lessee had the funds available and paid the highest price being offered by the bidders. Here, yes, the buyer was on the table at the beginning of the process, but the seller did not have confidence that the price being offered was the best possible price. After our program was implemented, the bids pushed the lessee’s offer up and a deal was made with the seller feeling 100% confident that the absolute top-of-the-market price was obtained for the site. One of the main reasons why we have been so successful over the years is our ability to maximize the sale prices we get for our seller.  The initial offer was $63 million. We closed at $74,700,000! Here is what the seller had to say: “When our tenant first approached us about potentially acquiring the property in an off market situation, we initially had planned to negotiate with them directly given our past history. However, after working with Bob, Jon, and Karl on a similar transaction in the immediate neighborhood, we realized that their knowledge of the development market and experience with these types of purchasers could be incredibly helpful to our negotiations. As a result, we engaged them to exclusively represent us during the process and could not be happier with the results it produced for us as it was a new record price for the area. I would encourage anyone with a similar situation to do the same!” - Meir Milgraum, Lightstone Group

AI-enabled medical devices authorized by the FDA most commonly perform quantitative image analysis, but recent trends show expanding applications beyond imaging. 1️⃣ Over 1,000 AI-enabled medical device authorizations were reviewed to understand trends and clinical applications. 2️⃣ The majority (84%) of devices use images (e.g., radiology scans) as inputs, although use of signals (e.g., ECG, EEG) is growing. 3️⃣ Most authorized devices (84%) support patient assessment tasks such as diagnosis or monitoring, rather than direct intervention. 4️⃣ AI's most common role (86%) is analyzing existing clinical data, rather than generating new data. 5️⃣ Devices frequently use AI for tasks like quantifying features (58%), triage (11%), or detection/diagnosis (11%). 6️⃣ Recent shifts show a relative decline in quantitative image analysis, with increased use in signal analysis and triage. 7️⃣ AI is increasingly utilized for generating new medical data, such as enhancing image quality or synthesizing data from other sources (11%). 8️⃣ No FDA-authorized medical device currently uses LLMs, despite AI’s growing diversity in application. 9️⃣ Current FDA classifications (product codes) are insufficiently detailed to capture the broad variability in AI applications. 🔟 Ongoing monitoring and detailed taxonomies are essential to track the evolving role and safety of AI-enabled medical devices. ✍🏻 Rohan Singh, Monika Bapna, Abdul Rahman Diab, Emily S. Ruiz, Bill Lotter. How AI is used in FDA-authorized medical devices: a taxonomy across 1,016 authorizations. npj Digital Medicine. 2025. DOI: 10.1038/s41746-025-01800-1

🚀What a year in the world of medical devices. We analyzed every medical device containing AI/ML cleared by the FDA in 2025. Here's what we found. 👇 → 62% were Software as a Medical Device (SaMD) → 71.5% focused on Radiology → 142 days median time to clearance → 183 companies received their first-ever AI/ML clearance → 10% used Predetermined Change Control Plans (PCCPs) → Only 9 companies achieved 4+ clearances What we learned: 𝟭. SaMD is the future. Software-centric solutions dominated, enabling rapid iteration, least burdensome approach, and ease of manufacture. 𝟮. Radiology leads, but challengers are emerging. Cardiovascular (8.8%) and Neurology (4.7%) are growing fast. 𝟯. Speed is a competitive advantage. 24% of devices cleared in under 90 days. Well-prepared submissions win. 𝟰. PCCPs are coming of age. Early adopters are positioning for continuous improvement without repeated submissions. The bottom line: The AI/ML regulatory framework is maturing. The technology is advancing and the flywheel is getting up to speed. Whether you're an established player or an innovative startup, the path to market has never been clearer—or more competitive. Don't get left behind in 2026. Read our complete analysis with detailed breakdowns of every trend, product code, and company. 👇 https://hubs.li/Q03YPpk-0